Evolent Health, Inc.EVHNYSE
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
45.45%
↑ 142% above average
Average (39q)
-109.25%
Historical baseline
Range
High:143.67%
Low:-2830.51%
CAGR
-0.9%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 45.45% |
| Q2 2025 | 30.16% |
| Q1 2025 | -133.33% |
| Q4 2024 | 0.00% |
| Q3 2024 | -384.74% |
| Q2 2024 | 74.68% |
| Q1 2024 | 38.89% |
| Q4 2023 | -20.00% |
| Q3 2023 | 3.23% |
| Q2 2023 | -63.16% |
| Q1 2023 | -72.73% |
| Q4 2022 | -650.00% |
| Q3 2022 | 143.67% |
| Q2 2022 | 23.41% |
| Q1 2022 | 6.42% |
| Q4 2021 | 57.40% |
| Q3 2021 | -36.36% |
| Q2 2021 | 8.33% |
| Q1 2021 | 29.41% |
| Q4 2020 | 61.36% |
| Q3 2020 | 81.51% |
| Q2 2020 | -158.70% |
| Q1 2020 | 61.02% |
| Q4 2019 | -686.67% |
| Q3 2019 | 21.05% |
| Q2 2019 | 35.59% |
| Q1 2019 | -180.95% |
| Q4 2018 | -31.25% |
| Q3 2018 | -23.08% |
| Q2 2018 | 27.78% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 35.71% |
| Q2 2017 | 17.65% |
| Q1 2017 | -3.03% |
| Q4 2016 | -26.92% |
| Q3 2016 | -30.00% |
| Q2 2016 | 93.13% |
| Q1 2016 | -2830.51% |
| Q4 2015 | 65.76% |